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Clinical Trials
No Difference in 1-Year Mortality in the ACUITY Trial of Bivalirudin
TheACUITY trial found that in acute coronary syndrome (ACS)patients, bivalirudinresulted in less major bleeding and similar ischemic outcomes at 30 days compared
withheparin-basedregimens. Inthisarticle,Whiteandcolleaguesextendedthefollow-upto
1 year. At 1 year, therewere no differences in composite ischemia ormortality between the
groups. TheACUITY trial demonstrated that bivalirudin decreases in-hospital bleeding in
ACSpatientswithout increasing the risk of ischemic events, but itmayhave been too small
to demonstrate a reduction in 1-year mortality. See page 807. See figure.
Clinical Trials
Similar Outcomes at 10 Years for CABG Versus PCI of Proximal LAD Lesions
The SIMA (Stent versus Internal Mammary Artery grafting) trial randomized 120patientswithsinglevesseldiseaseof theproximal leftanteriordescendingartery(LAD)
to either coronary artery bypass grafting (CABG) or percutaneous coronary intervention
(PCI)withabare-metal stent.After10years,42%of thePCIgroupand17%of theCABG
group reached an end point (p 0.001). The difference was primarily due to restenosis
during thefirst year in thePCIgroup.Over10years, the incidenceofdeathandmyocardial
infarction was identical at 10%. There was no difference in angina functional class. Both
stent implantation and CABG are safe, effective, and durable for relieving symptoms in
patients with isolated, proximal LAD stenosis. See page 815.
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Heart Failure
Anemia Associated With a 2-Fold Greater Risk of Death in Patients with
Heart Failure
Groenveld and colleagues performed a systematic meta-analysis of studies thatexamined the relationship between anemia and mortality in patients with
chronic heart failure (CHF). Thirty-four studies comprising over 150,000 patients
were included.Nearly 40%of patients were anemic, although the definition of anemia
varied in the studies. The risk of deathwas twice as high in anemic patients, and the risk
increased with greater severity of anemia. This risk persisted after adjusting for con-
founding conditions. This study confirms that anemia is a powerful prognosticator for
the risk of death in patients with CHF. See page 818. See figure.
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Heart Rhythm Disorders
BW Defibrillations Reduce Calcium Current Heterogeneity
Hwang and colleagues hypothesized that biphasic waveform (BW) shocks defi-brillate more effectively than monophasic waveform (MW) shocks because of
their differential effects on calcium currents. They simultaneously mappedmembrane
potential (Vm) and intracellular calcium (Cai) duringMWand BW shocks in isolated
rabbit ventricles. Biphasic waveform shocks resulted in less post-shock heterogeneity of
VmandCai thanMWshocks of the same strength andwere effective at lower voltages.
The defibrillation threshold became similar after calcium release from the sarcoplasmic
reticulum was blocked. These results outline the physiology for the improved efficacy
of BW compared with MW defibrillations. See page 828. See figure.
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Cardiac Imaging
Electroanatomic Mapping for Identifying Post-Infarct Scar
In patients with post-infarct ventricular arrhythmias, identifying the extent andlocation of scarring is necessary for planning ablation procedures. Codreanu and
colleagues compared electroanatomicmappingusing theCARTOsystemwithdelayed
contrast magnetic resonance imaging (MRI). Electrogram (EGM) parameters, such as
spiky EGMmorphology, reduced voltage, and longer EGM duration, independently
correlatedwith the presence of scar, but correlated poorly with intramural scar location
andnot at all with scar depth. A clearmismatchwas observed in one-third of cases. The
accuracy of endocardial mapping for precise scar delineation is limited. See page
839. See figure.
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Valvular Heart Disease
Increased Oxidative Stress in Stenosed Aortic Valves
Miller and colleagues hypothesized that increased oxidative stress may contributeto the progression of aortic valvular stenosis and calcification. Explanted valves
from patients undergoing aortic valve replacement for aortic stenosis (AS) were com-
paredwith valve leaflets fromhearts explanted for possible transplantation. Superoxide
levels were increased 2-fold near the calcified regions of the stenotic valves; hydrogen
peroxide levelswere alsomarkedly elevated.This studyprovides evidence that oxidative
stress is increased in calcified regions of stenotic aortic valves and that this stress is due
to reduction in the expression and activity of antioxidant enzymes. See page 843.
See figure.
